← Back to Search

Survivorship Care Coordination for Prostate Cancer

N/A
Waitlist Available
Led By Ronald C Chen
Research Sponsored by NRG Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The ADT must be planned for at least 4 months and must include luteinizing hormone-releasing hormone (LHRH) agonist or LHRH antagonist
The participant must be able to complete required questionnaires in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 24 months after completion of radiation therapy (rt)
Awards & highlights

Study Summary

This trial is testing whether increasing the coordination of care between the cancer care team and the primary care team improves care and outcomes for prostate cancer survivors.

Who is the study for?
This trial is for prostate cancer survivors who are undergoing radiation and androgen deprivation therapy. They must be able to fill out questionnaires in English, have a primary care provider or cardiologist, and consent to the study. Practices need IRB approval, complete specific training, and follow certain protocols. Patients already on ADT for no more than 120 days may join.Check my eligibility
What is being tested?
The trial tests if increasing survivorship care planning can improve outcomes for prostate cancer survivors on therapy that raises risks of diabetes and heart issues. It compares standard care with an increased dose of coordinated survivorship care between oncologists and primary caregivers.See study design
What are the potential side effects?
Since this trial focuses on survivorship care planning rather than a medical intervention, there are no direct side effects from treatments like drugs or surgery being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for hormone therapy for my cancer for at least 4 months.
Select...
I can complete questionnaires in English.
Select...
I have prostate cancer and will be treated with radiation and hormone therapy aiming for a cure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 24 months after completion of radiation therapy (rt)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 24 months after completion of radiation therapy (rt) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients who saw a primary care provider (PCP) or cardiologist and had their cholesterol checked
Proportion of patients who saw a primary care provider (PCP) or cardiologist and had their fasting blood glucose checked
Secondary outcome measures
Eligible screened patients with a PCP or cardiologist
High health literacy levels

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Survivorship Care Plan (SCP)Experimental Treatment3 Interventions
Practices review a treatment plan with patient and send it to the PCP at the beginning of RT. Practices also review a SCP with patients and send it to the PCP during the last week of RT.
Group II: Standard Survivorship Care Plan (SCP)Active Control2 Interventions
Practices review a SCP with patients and send it to the PCP during the last week of RT.

Find a Location

Who is running the clinical trial?

NRG OncologyLead Sponsor
231 Previous Clinical Trials
100,018 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,655 Previous Clinical Trials
40,932,385 Total Patients Enrolled
Ronald C ChenPrincipal InvestigatorNRG Oncology
1 Previous Clinical Trials
586 Total Patients Enrolled

Media Library

Survivorship Care Planning Clinical Trial Eligibility Overview. Trial Name: NCT03860961 — N/A
Prostate Adenocarcinoma Research Study Groups: Standard Survivorship Care Plan (SCP), Enhanced Survivorship Care Plan (SCP)
Prostate Adenocarcinoma Clinical Trial 2023: Survivorship Care Planning Highlights & Side Effects. Trial Name: NCT03860961 — N/A
Survivorship Care Planning 2023 Treatment Timeline for Medical Study. Trial Name: NCT03860961 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many sites are partaking in this experimental program?

"This clinical trial is taking place at the University of Kansas Cancer Centre in Lee's Summit, Missouri; Minnesota Oncology Hematology PA-Maplewood in Maplewood, Minnesota; and Christiana Care Health System-Christiana Hospital in Newark, Delaware to name a few out of 73 sites."

Answered by AI

Are there any slots still available to participate in this investigation?

"Unfortunately, as per the clinicaltrials.gov website, this particular research trial is not in need of any additional patients at present. The study launched on August 2nd 2019 and was last updated on July 29th 2022; however there are still 838 other medical trials actively recruiting participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy
2019. "Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03860961.
All > New Mexico > Paid Studies Maine
~93 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top